par Reenaers, Catherine;Bossuyt, Peter;Hindryckx, Pieter P.M.;Vanpoucke, Hilde;Cremer, Anneline
;Baert, Filip
Référence United European gastroenterology journal, 6, 8, page (1117-1125)
Publication Publié, 2018-10-01

Référence United European gastroenterology journal, 6, 8, page (1117-1125)
Publication Publié, 2018-10-01
Article révisé par les pairs
Résumé : | Despite many publications regarding the role of faecal calprotectin (FC) in inflammatory bowel disease (IBD), clear recommendations for its use in clinical practice are currently lacking in the literature. |